Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: A multi-national study

Clinical Microbiology and Infection

Volumn 20, Issue 11, 2014, Pages 1219-1224

  Tornero, E ^a   Senneville, E ^b   Euba, G ^c   Petersdorf, S ^d   Rodriguez Pardo, D ^e   Lakatos, B ^f   Ferrari, M C ^g   Pilares, M ^h   Bahamonde, A ⁱ   Trebse, R ^j   Benito, N ^k   Sorli, L ^l   del Toro, M D ^m   Baraiaetxaburu, J M ⁿ   Ramos, A ^o   Riera, M ^p   Jover Saenz A ^q   Palomino, J ^r   Ariza, J ^c   Soriano, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Infectious Diseases Department Gustave Dron Hospital of Tourcoing   (France)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Szent Laszlo Hospital   (Hungary)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ HOSPITAL EL BIERZO   (Spain)

^j Valdoltra Orthopaedic Hospital   (Slovenia)

^k UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^l Hospital Universitari del Mar   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

ⁿ HOSPITAL DE BASURTO   (Spain)

^o HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^p HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^q HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^r HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

more..

Author keywords

Enterococcus faecalis; Enterococcus faecium; Debridement; One stage exchange; Outcome; Prosthetic joint infection; Two stage exchange

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; DAPTOMYCIN; LINEZOLID; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTHROPLASTY; ARTHROSCOPIC DEBRIDEMENT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEVICE REMOVAL; DISEASE ASSOCIATION; ELBOW PROSTHESIS; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; FEVER; HIP PROSTHESIS; HUMAN; KNEE PROSTHESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS FAILURE; PROSTHESIS INFECTION; REMISSION; RISK FACTOR; SHOULDER PROSTHESIS; TREATMENT DURATION; ARTHRITIS; CLINICAL TRIAL; COINFECTION; ENTEROCOCCUS; EUROPE; GRAM-POSITIVE BACTERIAL INFECTIONS; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDY; VERY ELDERLY;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS SP.;

AGED; AGED, 80 AND OVER; ARTHRITIS; COINFECTION; COMORBIDITY; ENTEROCOCCUS; EUROPE; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES;

EID: 84916938331     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12721     Document Type: Article

References (25)

1. Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J. Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 2008; 466: 1710-1715.
2. Soriano A, Bori G, García-Ramiro S et al. Timing of antibiotic prophylaxis for primary total knee arthroplasty performed during ischemia. Clin Infect Dis 2008; 46: 1009-1014.
3. Yokoe DS, Avery TR, Platt R, Huang SS. Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis 2013; 57: 1282-1288.
4. Moran E, Byren I, Atkins BL. The diagnosis and management of prosthetic joint infections. J Antimicrob Chemother 2010; 65(suppl 3): iii45-54.
5. Peel TN, Cheng AC, Buising KL, Choong PFM. Microbiological aetiology, epidemiology, and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother 2012; 56: 2386-2391.
6. Berbari EF, Osmon DR, Duffy MCT et al. Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes. Clin Infect Dis 2006; 42: 216-223.
7. Marculescu CE, Berbari EF, Hanssen AD et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42: 471-478.
8. Moran E, Masters S, Berendt AR et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect 2007; 55: 1-7.
9. Soriano A, Garcia S, Bori G et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006; 12: 930-933.
10. Lora-Tamayo J, Euba G, Ribera A et al. Infected hip hemiarthroplasties and total hip arthroplasties: differential findings and prognosis. J Infect 2013; 67: 536-544.
11. El Helou OC, Berbari EF, Marculescu CE et al. Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis 2008; 47: 903-909.
12. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654.
13. Bejon P, Berendt A, Atkins BL et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 2010; 65: 569-575.
14. Rasouli MR, Tripathi MS, Kenyon R et al. Low rate of infection control in enterococcal periprosthetic joint infections. Clin Orthop Relat Res 2012; 470: 2708-2716.
15. Vilchez F, Martínez-Pastor JC, Garcia-Ramiro S et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011; 17: 439-444.
16. Senneville E, Joulie D, Legout L et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 2011; 53: 334-340.
17. Sandoe JAT, Witherden IR, Cove JH, Heritage J, Wilcox MH. Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo. J Med Microbiol 2003; 52: 547-550.
18. Sandoe JAT, Wysome J, West AP, Heritage J, Wilcox MH. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 2006; 57: 767-770.
19. Holmberg A, Morgelin M, Rasmussen M. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother 2012; 67: 433-439.
20. Gavaldà J, Torres C, Tenorio C et al. Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother 1999; 43: 639-646.
21. Euba G, Lora-Tamayo J, Murillo O et al. Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis. Antimicrob Agents Chemother 2009; 53: 4305-4310.
22. Sakoulas G, Nonejuie P, Nizet V et al. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Antimicrob Agents Chemother 2013; 57: 4042-4045.
23. Sakoulas G, Bayer AS, Pogliano J et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2012; 56: 838-844.
24. Descourouez JL, Jorgenson MR, Wergin JE, Rose WE. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid, against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents. Antimicrob Agents Chemother 2012; 57: 1518-1520.
25. Wolf CF, Gu NY, Doctor JN, Manner PA, Leopold SS. Comparison of one and two-stage revision of total hip arthroplasty complicated by infection: a Markov expected-utility decision analysis. J Bone Joint Surg Am 2011; 93: 631-639.